Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1995; 74(01): 511-514DOI: 10.1055/s-0038-1642730 Symposium Clinical Coagulation Laboratory and Oral Anticoagulant Therapy Treatment Schattauer GmbH Stuttgart Clinical Coagulation Laboratory and Oral Anticoagulant Therapy Treatment. Instrumentation and Methodology Tizsano Barbui Hematology Division, Ospedaii Riuniti, Bergamo, Italy , Guido Finazzi Hematology Division, Ospedaii Riuniti, Bergamo, Italy , Andrea Remuzzi Mario Negri Institute, Bergamo, Italy › Author Affiliations Recommend Article Abstract PDF Download Buy Article PDF (299 kb) References References 1 Hirsh J. Oral anticoagulant drugs. N Engl J Med 1991; 324: 1865-75 2 Ansell JE. Oral anticoagulant therapy-50 years later. Arch Intern Med 1993; 153: 586-596 3 British Society for Haematology. Guidelines on oral anticoagulation: second edition. J Clin Pathol. 1990; 43: 177-183 4 Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH. Risk factor for complications of chronic anticoagulation. A multicenter study. Ann Intern Med 1993; 118: 511-20 5 WHO Expert Committee on Biological Standardization. 31st Report. WHO Tech Ser 1981; 658: 185-205 6 Poller L, Tabemer DA, Thomson JM, Darby KV. Survey of prothrombin time results in National External Quality Assessment Scheme exercises 1980-87. J Clin Pathol 1988; 41: 361-4 7 Brophy MT, Fiore LD, Lau J, Goodwin R, Lopez A, Deykin D. Comparison ofa standard and a sensitive thromboplastin in monitoring low intensity oral anticoagulant therapy. Am J Clin Pathol 1994; 102: 134-137 8 Bader R, Mannucci PM, Tripodi A, Hirsh J, Keller F, Solleder EM, Hawkins P, Peng M, Pelzer H, Teijdor LM, Ramirez IF, Kolde HJ. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemostas 1994; 71: 292-299 9 Finazzi G, Falanga A, Galli M, Cortelazzo S, Remuzzi A, Barbui T. Recombinant versus high-sensitivity conventional thromboplastin: a randomized clinical study in patients on oral anticoagulation. Thromb Haemostas 1994; 72: 804-807 10 Eckman MH, Levine HI, Pauker SG. Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med 1993; 329: 696-702 11 Kitchen S, Walker ID, Woods TAL. Preston. Thromboplastin related differences in the determination of International Normalised Ratio: a cause for concern . Thromb Haemostas 1994; 72: 426-429 12 Becker DM, Humphries JE, Walker FB, DeMong LK, Bopp JS, Acker MN. Standardizing the prothrombin time:calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med 1993; 117: 602-605 13 Cunningham M, Johnson GF, Pennell BJ, Olson JD. The reliability of manufactuter-determined, instrument-specific international sensitivity index for calculating the international normalized ratio. Am J Qin Pathol 1994; 102: 128-133 14 Van Dijk-Wierda CA, Loeliger EA, Meilof J, Roos J. Anticoagulant control in the Netherlands. Lancet 1981; 1: 1321-1322 15 Kumar S, Haigh JRM, Rhodes LE, Peaker S, Davies JA, Roberts BE, Feely MP. Poor compliance is a major factor in unstable outpatients control of anticoagulant therapy. Thromb Haemostas 1989; 62: 729-732 16 Van den Besselaar AMHP, Van der Meer FJM, Gerrits-Drabbe CW. Therapeutic control of oral anticoagulant treatment in the Netherlands. Am J Clin Pathol 1988; 90: 685-690 17 Azar AJ, Deckers JW, Rosendaal FR, Van Bergen PFMM, Van der Meer FJM, Janker JJC, Briet E. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemostas 1994; 72: 347-351 18 Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications inpatients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641 19 Cortelazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemostas 1993; 69: 316-320 20 Taylor F, Ramsay M, Covell B, Gaminara L, Them son D, Cohen H, Voke J. Management of expanding anticoagulant clinics: a role for general practitioners. Br J Haematol 1994; 86 (01) 68 Abstract 21 Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Inter Med 1993; 153: 1441-1447 22 Patel N, Ostrovsky D, Fish L, Nozzolillo E, Peterson A, Ansell J. Long-term patient self-monitoring and self-management of oral anticoagulation therapy with a capillary whole blood analyzer. Blood 1994; 84 (01) 69a Abstract 23 Tripodi A, Arbini A, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio. Thromb Haemostas 1993; 70: 921-924
